# Bioinpe

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/bioinpe

- Industry: Materials
- Headquarters: Changzhou, China
- Website: www.bioinpe.com
- Latest round: Series A (Apr 30, 2024)
- Investors on record: 1

## About

Bioinpe is a biotechnology firm focused on developing advanced biomaterials and peptide technologies, emphasizing innovative solutions in health and beauty industries through its proprietary self-assembling peptides.Bioinpe, founded in 2023, operates in Changzhou, China, specializing in biotechnology. The company has completed one deal, with its most recent deal dated April 30, 2024. The founder's history is currently not available.Bioinpe specializes in the development and production of advanced biomaterials and peptide technologies, primarily focusing on intelligent self-assembling short peptides. The company's core product offerings leverage supramolecular technology for various applications in pharmaceuticals, cosmetics, and biomedicine. Its diverse clientele includes manufacturers and distributors in the biopharmaceutical and cosmetic industries across North America, Europe, and parts of Asia, with ongoing research and development initiatives enhancing product evolution.The revenue model of Bioinpe is driven by B2B transactions, focusing on partnerships with manufacturers and distributors in biopharmaceutical and cosmetic sectors. Direct sales of flagship products, such as self-assembling peptide solutions, facilitate various applications in health supplements and skincare formulations through structured contracts, ensuring consistent revenue streams that reflect the advanced nature of their offerings.In April 2024, Bioinpe raised an undisclosed amount of Series A funding led by Green Pine Capital Partners. The company intends to utilize this funding for technology optimization, new product development, market promotion, and construction of a production base. Plans for expansion target new geographic regions, including increased market penetration in North America and Europe by the end of 2025.

## Funding rounds

- Series A, Apr 30, 2024 — Green Pine Capital Partners

## Investors

- Green Pine Capital Partners (https://capitalatlas.ai/funds/green-pine-capital-partners) — Series A